| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.28 | 0.09 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.3 | 0.09 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |